ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Alopecia universalis

Joanne Kurtzberg, MD – Autism Joanne Kurtzberg, MD – Autism Spectrum Disorder EyeTechCare – Refractory Open Angle Glaucoma

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata Tofacitinib for the Treatment of Alopecia Areata and Its Variants Tofacitnib for the Treatment of Alopecia Areata and Variants Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata Alopecia Areata Registry Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT) Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis Efalizumab in the Treatment of Alopecia, Phase II Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata